FR2741804B1 - Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens - Google Patents

Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens

Info

Publication number
FR2741804B1
FR2741804B1 FR9514240A FR9514240A FR2741804B1 FR 2741804 B1 FR2741804 B1 FR 2741804B1 FR 9514240 A FR9514240 A FR 9514240A FR 9514240 A FR9514240 A FR 9514240A FR 2741804 B1 FR2741804 B1 FR 2741804B1
Authority
FR
France
Prior art keywords
iminobenzothiazolines
parkinson
disease
treatment
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9514240A
Other languages
English (en)
French (fr)
Other versions
FR2741804A1 (fr
Inventor
Alain Boireau
Marie Christine Dubroeucq
Assunta Imperato
Patrick Jimonet
Serge Mignani
John Randle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9514240A priority Critical patent/FR2741804B1/fr
Priority to PCT/FR1996/001867 priority patent/WO1997020558A1/fr
Priority to AU76994/96A priority patent/AU7699496A/en
Priority to JP9521025A priority patent/JP2000505060A/ja
Priority to EP96939977A priority patent/EP0863756A1/fr
Priority to ZA969968A priority patent/ZA969968B/xx
Publication of FR2741804A1 publication Critical patent/FR2741804A1/fr
Application granted granted Critical
Publication of FR2741804B1 publication Critical patent/FR2741804B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9514240A 1995-12-01 1995-12-01 Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens Expired - Fee Related FR2741804B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9514240A FR2741804B1 (fr) 1995-12-01 1995-12-01 Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
PCT/FR1996/001867 WO1997020558A1 (fr) 1995-12-01 1996-11-26 Application de 2-iminobenzothiazolines dans le traitement du parkinson et des syndromes parkinsoniens
AU76994/96A AU7699496A (en) 1995-12-01 1996-11-26 Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes
JP9521025A JP2000505060A (ja) 1995-12-01 1996-11-26 パーキンソン病およびパーキンソン症候群を処置するための２―イミノベンゾチアゾリン類の使用
EP96939977A EP0863756A1 (fr) 1995-12-01 1996-11-26 Application de 2-iminobenzothiazolines dans le traitement du parkinson et des syndromes parkinsoniens
ZA969968A ZA969968B (en) 1995-12-01 1996-11-27 Use of 2-iminobenzothiazolines in the treatment of parkinson's disease and parkinsonian syndromes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514240A FR2741804B1 (fr) 1995-12-01 1995-12-01 Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens

Publications (2)

Publication Number Publication Date
FR2741804A1 FR2741804A1 (fr) 1997-06-06
FR2741804B1 true FR2741804B1 (fr) 1998-01-02

Family

ID=9485069

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9514240A Expired - Fee Related FR2741804B1 (fr) 1995-12-01 1995-12-01 Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens

Country Status (6)

Country Link
EP (1) EP0863756A1 (ja)
JP (1) JP2000505060A (ja)
AU (1) AU7699496A (ja)
FR (1) FR2741804B1 (ja)
WO (1) WO1997020558A1 (ja)
ZA (1) ZA969968B (ja)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant

Also Published As

Publication number Publication date
WO1997020558A1 (fr) 1997-06-12
FR2741804A1 (fr) 1997-06-06
AU7699496A (en) 1997-06-27
JP2000505060A (ja) 2000-04-25
ZA969968B (en) 1997-06-13
EP0863756A1 (fr) 1998-09-16

Similar Documents

Publication Publication Date Title
EE9800158A (et) Epinastiin kasutamiseks valude ravis
IT9083334A0 (it) Procedimento per l'estrazione e la purificazione di dna genomico umano
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IL104797A0 (en) Treatment of disease employing hyaluronic acid and nsaids
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
FR2741355B1 (fr) Composition pour le traitement d'objets que l'on souhaite nettoyer et/ou desinfecter
AU2729400A (en) Application of a viral complement inhibitory protein in the treatment and diagnosis of alzheimer's disease
LU90118B1 (fr) Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
FR2756737B1 (fr) Application de la thalidomide au traitement de la maladie de parkinson et des syndromes parkinsoniens
NO974486D0 (no) Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse
FR2741804B1 (fr) Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
FR2774596B1 (fr) Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
FR2700115B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
EP0866799A4 (en) APOLIPOPROTEIN E2 AND TREATMENT OF ALZHEIMER'S DISEASE
FR2709964B1 (fr) Compositions pharmaceutiques antivirales proposées dans le traitement du SIDA et de l'Herpès.
GB9307948D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
FR2702149B1 (fr) Application de la lamotrigine dans le traitement du neuro-sida.
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
ZA969971B (en) Use of 2-aminobenzothiazoles in the treatment of parkinson's disease and parkinsonian syndromes
FR2717382B1 (fr) Extraits de Paeonia Lactiflora titré en paeoniflorine utiles en cosmétologie dans le traitement capillaire.
FR2702151B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
EP0862442A4 (en) METHOD FOR DIAGNOSING AND TREATING BLOOM SYNDROME
FR2797273B1 (fr) Polynucleotides dirigeant l'activation de l'expression d'un gene dans le coeur et ses applications a la therapie genique

Legal Events

Date Code Title Description
ST Notification of lapse